{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:37:37Z","timestamp":1770064657005,"version":"3.49.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2025,11,2]]},"DOI":"10.1080\/14740338.2024.2393279","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T08:29:26Z","timestamp":1723624166000},"page":"1359-1366","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["A pharmacovigilance study assessing risk of angioedema with angiotensin receptor blockers using the US FDA Adverse Event Reporting System"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-6503","authenticated-orcid":false,"given":"Kannan","family":"Sridharan","sequence":"first","affiliation":[{"name":"Arabian Gulf University","place":["Manama, Kingdom of Bahrain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowri","family":"Sivaramakrishnan","sequence":"additional","affiliation":[{"name":"PHCC","place":["Manama, Kingdom of Bahrain"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"e_1_3_6_2_1","unstructured":"Hill RD Vaidya PN. Angiotensin II receptor blockers (ARB). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan [cited 2023 Mar 27]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537027\/"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP171917.OR"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.07.108"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz263"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03261835"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.13097"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0815-5"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12866"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.14.1637"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07371009"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.05.054"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0859-x"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19294"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-008-0668-3"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/1470320310370852"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000131497.73744.1a"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12867"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60288-8"},{"key":"e_1_3_6_20_1","unstructured":"Questions and Answers on FDA\u2019s Adverse Event Reporting System (FAERS). United States Food and Drug Administration. [cited 2024 May 27]. Available from: https:\/\/www.fda.gov\/drugs\/surveillance\/questions-and-answers-fdas-adverse-event-reporting-system-faers"},{"key":"e_1_3_6_21_1","unstructured":"Standardised MedDRA queries. [cited 2024 May 28]. Available from: https:\/\/www.meddra.org\/standardised-meddra-queries"},{"key":"e_1_3_6_22_1","unstructured":"Medical Dictionary for Regulatory Activities Terminology (MedDRA). Angioedema (SMQ). [cited 2024 Aug 14]. Available at: https:\/\/bioportal.bioontology.org\/ontologies\/MEDDRA?p=classes&conceptid=20000024"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2019.01.006"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1001"},{"key":"e_1_3_6_25_1","unstructured":"USFDA. Good pharmacovigilance practices and pharmacoepidemiologic assessment. [cited 2024 Jun 1]. Available from: https:\/\/www.fda.gov\/files\/drugs\/published\/Good-Pharmacovigilance-Practices-and-Pharmacoepidemiologic-Assessment-March-2005.pdf"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2023.100809"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2012.12.017"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225020-00001"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2005.01547.x"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000153269.07762.3B"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.12890\/2019_001128"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14314"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.10064SC"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088542"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411649"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/2013.jamainternmed.34"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13097"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24110"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2393279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:06:31Z","timestamp":1762149991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2393279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,2]]}},"alternative-id":["10.1080\/14740338.2024.2393279"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2393279","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}